3.26
price down icon4.40%   -0.15
after-market 시간 외 거래: 3.22 -0.04 -1.23%
loading

Endra Life Sciences Inc (NDRA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-09-30 2025-06-30 2025-03-31 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
5.35%
1.3707
1.3011 1.4693 2.2309 2.7805
Operating Income/Loss
5.35%
-1.3707
-1.3011 -1.4693 -2.2309 -2.7805
Nonoperating Income/Loss
-0.2253
- - 0.0017 0.00484
Income/Loss From Continuing Operations Before Tax
30.19%
-1.596
-1.2259 -1.0363 -2.2292 -2.7757
Income/Loss From Continuing Operations After Tax
30.19%
-1.596
-1.2259 -1.0363 -2.2292 -2.7757
Net Income/Loss
30.19%
-1.596
-1.2259 -1.0363 -2.2292 2.7757
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - 5.5514
Basic Average Shares
0.7612
- - - -
Diluted Average Shares
0.7612
- - - -
Basic Earnings Per Share
-2.10
- - - -
Diluted Earnings Per Share
-2.10
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research DGX
$194.16
price down icon 0.55%
diagnostics_research LH
$264.09
price down icon 0.66%
diagnostics_research MTD
$1,190.49
price down icon 0.09%
diagnostics_research IQV
$166.47
price down icon 0.33%
$202.73
price up icon 2.50%
diagnostics_research WAT
$299.57
price up icon 1.53%
자본화:     |  볼륨(24시간):